Red Nucleus Acquires Jupiter Life Science Consulting
September 12, 2022
Red Nucleus, a Riverside-backed life sciences services platform, has acquired Jupiter Life Science Consulting, a boutique provider of market access and commercialization strategies for pharma, biotech, and medical device clients. The add-on expands Red Nucleus's commercial and market-access capabilities, bringing Jupiter's expertise in payer research, pricing and access strategy, and commercialization planning into the combined platform.
- Buyers
- Red Nucleus, The Riverside Company
- Targets
- Jupiter Life Science Consulting
- Platforms
- Red Nucleus
- Industry
- Consulting
- Location
- United States
- Transaction Type
- Addon
Explore More
Related Acquisitions
-
The Riverside Company Acquires Red Nucleus from Renovus Capital Partners
March 24, 2020
Education
The Riverside Company has acquired Red Nucleus Enterprises, LLC, a Yardley, Pennsylvania-based provider of digital learning and regulatory compliance services for the life sciences industry. Renovus Capital Partners sold the company to Riverside but retained a minority equity stake and will continue to support future growth; Riverside plans to expand Red Nucleus's training offerings, technology capabilities and pursue add-on acquisitions.
-
Red Nucleus Acquires COEUS
February 4, 2025
Healthcare Services
Red Nucleus, a global strategic partner to life sciences companies, has acquired COEUS, a market access consulting and communications firm. The deal augments Red Nucleus' market access capabilities—particularly payor outreach, HEOR, patient access, and commercialization support—strengthening services for pharmaceutical and biotech clients.
-
THL Partners Acquires Majority Stake in Red Nucleus from The Riverside Company
October 17, 2024
Healthcare Services
THL Partners (Thomas H. Lee Partners) has made a majority investment in Red Nucleus, a Yardley, Pennsylvania-based provider of medical communications, market access, learning & development, and R&D support for the life sciences industry. The Riverside Company sold its investment in Red Nucleus; the deal closed October 17, 2024 and will support expansion of Red Nucleus’ commercialization services under new CEO Mike Menta and continued involvement from founder Ian Kelly.
-
Red Nucleus Acquires Bridge Medical Consulting
February 5, 2026
Healthcare Services
Red Nucleus has acquired Bridge Medical Consulting, a UK-based health economics and outcomes research (HEOR) consultancy, to broaden its HEOR, real-world evidence, and market access capabilities for biopharmaceutical clients. The firm will be merged into Red Nucleus's existing HEOR business to expand evidence synthesis, economic modeling, RWE research, and AI-enabled workflows.
-
Red Nucleus (backed by The Riverside Company) Acquires Life Science Training Institute (LSTI)
September 14, 2020
Healthcare Services
Red Nucleus, a life-sciences learning and training platform backed by The Riverside Company, acquired Life Science Training Institute (LSTI), a provider of on-demand, live, and custom compliance training for pharmaceutical, biotech and medical device customers. The add-on transaction (closed September 2020) expands Red Nucleus's R&D e-learning and compliance capabilities and brings LSTI's subscription library of over 200 courses into RN's platform.
-
Red Nucleus / Riverside Acquire INVIVO Communications
September 30, 2020
Healthcare Services
Red Nucleus, the life-sciences learning and performance platform backed by The Riverside Company, acquired Toronto-based INVIVO Communications, a digital scientific communications agency. The deal is an add-on to Riverside's Red Nucleus platform, expanding RN's medical communications and digital scientific communications capabilities; the combined business now totals 360+ employees across seven locations.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.